# Single Dose Versus Two Weeks Course of Fluconazole in the Treatment of Oropharyngeal Candidiasis in HIV Infected Individuals in Tanzania

> **NCT00553137** · PHASE4 · COMPLETED · sponsor: **Netherlands Organisation for Scientific Research** · enrollment: 220 (actual)

## Conditions studied

- Oropharyngeal Candidiasis

## Interventions

- **DRUG:** fluconazole
- **DRUG:** fluconazole

## Key facts

- **NCT ID:** NCT00553137
- **Lead sponsor:** Netherlands Organisation for Scientific Research
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2008-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00553137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00553137, "Single Dose Versus Two Weeks Course of Fluconazole in the Treatment of Oropharyngeal Candidiasis in HIV Infected Individuals in Tanzania". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00553137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*